Showing results (641-650 of 1,481) with videos related to
Sort By:
Pageof 149
Human Psychopharmacology|October 4, 2022
Plasma levels of interleukin-8 and response to paroxetine in patients with major depressive disorderXuan Guan, Zai-Quan Dong, Yan-Ni Hao, et al.Human Psychopharmacology|November 20, 2023
Factors influencing concentrations of risperidone and 9-hydroxyrisperidone in psychiatric outpatients taking immediate-release formulations of risperidoneZhihao Guo, Chunxiu Chen, Shuhua Deng, et al.Human Psychopharmacology|January 5, 2024
Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in JapanKeisuke Aoyama, Tomoya Tachi, Satoaki Kubo, et al.Human Psychopharmacology|July 12, 2024
Bi-directional and multi-modal effects of dexamphetamine on spatial binding windows in healthy individualsMark J H Lim, Sean J Loffman, Katharina Gaus, et al.Human Psychopharmacology|September 30, 2023
Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker surveyMatthew Jones, Amira Guirguis, Alan Watkins, et al.Human Psychopharmacology|September 15, 2023
Efficacy and acceptability of adjunctive n-acetylcysteine for psychotic disorders: Systematic review and meta-analysisQun Zhang, Ziping Liu, Ting Wang, et al.Human Psychopharmacology|June 8, 2023
The impact of alcohol consumption on commercial eye blink drowsiness detection technologyJennifer M Cori, Vanessa E Wilkinson, Melinda Jackson, et al.Human Psychopharmacology|March 14, 2018
Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasksAsuka Kikuchi, Fairuz Binti Mohammadi Nasir, Akie Inami, et al.Human Psychopharmacology|September 25, 2020
The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort studyPhilip Gorwood, Jacques Benichou, Nicholas Moore, et al.Human Psychopharmacology|September 23, 2020
Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyondMaju Mathew KoolaPageof 149